In this live educational webinar, Guillermo E. Umpierrez, MD, Professor of Medicine at Emory University, provides an evidence-based overview of the benefits and concerns associated with the real-world use of GLP-1 and GIP/GLP-1 receptor agonists.
The session examines their impact on glycemic control, weight management, and cardio-renal outcomes, and reviews emerging evidence in conditions such as fatty liver disease and obstructive sleep apnea, alongside key safety considerations. Based on data from randomized trials, meta-analyses, and real-world studies, this webinar supports physicians in clinical decision-making, patient selection, and expectation management when prescribing GLP-1–based therapies in routine practice.
To access the live webinar on the event day, you need a Xpeer account. Don’t have one yet? Register for free here.
March 5th
17h CET
Live on Xpeer
Speaker
Dr. Guillermo Umpierrez is a professor of medicine in the Division of Endocrinology and the past president of the American Diabetes Association for Medicine and Science, 2022.
Key takeaways
- Assess the clinical benefits and risks of GLP-1 and GIP/GLP-1 receptor agonists in real-world practice.
- Interpret evidence on glycemic, cardio-renal, and metabolic outcomes associated with GLP-1–based therapies.
- Integrate safety and real-world considerations into clinical decision-making for patients with type 2 diabetes.
Xpeer: flexible, interactive and 100% online
Choose your favourite device. Download the app and stay up to date anytime, anywhere.
.webp "Download the app")
